Lcm Capital Management Inc Cyma Bay Therapeutics, Inc. Transaction History

Lcm Capital Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 24, 2022	SELL	$3.23 - $4.6 $32,300 - $46,000	-10,000 Closed	0 $0
Q3 2021 Oct 15, 2021	BUY	$3.47 - $4.42 $34,700 - $44,200	10,000 New	10,000 $37,000
Q2 2021 Jul 21, 2021	SELL	$3.94 - $4.92 $39,400 - $49,200	-10,000 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$4.23 - $6.55 $42,300 - $65,500	10,000 New	10,000 $45,000

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Lcm Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Lcm Capital Management Inc with notifications on news.